146 related articles for article (PubMed ID: 6236358)
21. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
Douglas JT; Shah M; Lowe GD; Belch JJ; Forbes CD; Prentice CR
Thromb Haemost; 1982 Feb; 47(1):54-5. PubMed ID: 6176042
[TBL] [Abstract][Full Text] [Related]
22. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
Hayashi I
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of septic pelvic thrombophlebitis by measurement of fibrinopeptide A.
Weiner CP; Kwaan H; Duboe F
Am J Perinatol; 1985 Apr; 2(2):93-5. PubMed ID: 4096764
[TBL] [Abstract][Full Text] [Related]
24. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
[TBL] [Abstract][Full Text] [Related]
25. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
[TBL] [Abstract][Full Text] [Related]
26. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
27. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
28. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
29. Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A.
Amiral J; Walenga JM; Fareed J
Semin Thromb Hemost; 1984 Oct; 10(4):228-42. PubMed ID: 6393350
[TBL] [Abstract][Full Text] [Related]
30. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
31. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
Burrows AW
Horm Metab Res Suppl; 1981; 11():22-5. PubMed ID: 6172350
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism.
van Hulsteijn H; Briƫt E; Koch C; Hermans J; Bertina R
Acta Med Scand; 1982; 211(5):323-30. PubMed ID: 6180602
[TBL] [Abstract][Full Text] [Related]
33. Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assay.
Marongiu F; Mamusa AM; Mameli G; Conti M; Sorano GG; Biondi G; Farci P; Balestrieri A
Ric Clin Lab; 1989; 19(2):157-63. PubMed ID: 2528202
[TBL] [Abstract][Full Text] [Related]
34. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
[TBL] [Abstract][Full Text] [Related]
35. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
[TBL] [Abstract][Full Text] [Related]
36. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
37. Activation of coagulation and fibrinolytic systems following stroke.
Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
[TBL] [Abstract][Full Text] [Related]
38. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
39. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
40. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Mombelli G; Roux A; Hofmann V; Straub PW
Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]